As Beijing patent pilot and intellectual property implementing standard enterprise, Shenogen has applied for nearly 50 patents and 11 PCTs of antibody, small molecule and ADC drugs development. Till now, we have 24 patents granted by China, USA, Japan, Canada, Australia and other countries. It is comprehensive protection of our drug target, structure, usage and formulation. Our company also has 12 trademark registrations under examination.

   Intellectual Property